Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer
Stopped early · Phase 2
Conditions studied: Prostate Cancer
In brief
The purpose of this research is to determine the effectiveness of CGC-11047 in subjects with metastatic hormone refractory prostate cancer as measured by changes in PSA.
Key facts
- Study ID
- NCT00585416
- Run by
- University of Wisconsin, Madison
- People needed
- 23
- Starts
- 2006-06-01
- Expected to finish
- 2009-03-01
- Last updated by the study team
- 2015-10-02
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Metastatic hormone refractory prostate cancer.
- Eastern Cooperative Oncology Group (ECOG) Performance status of 0-1.
- testosterone <50ng/dL. Patients must continue primary androgen deprivation with an LHRH analogue if they have not undergone orchiectomy.
- Progressive disease after androgen deprivation.
You may not qualify if…
- Patients whose clinical condition would make chemotherapy clearly indicated.
- Patients who have received systemic chemotherapy for the treatment of metastatic disease.
- Peripheral neuropathy > Grade 1
- Prior anti-angiogenic therapy, including thalidomide.
- Patients with inadequate recovery from any prior surgical procedure, or patients having undergone any major surgical procedure or radiation within 4 weeks prior to study entry.
- Patients who have received radiopharmaceuticals (strontium, samarium) within 8 weeks prior to enrollment.
- Patients with known brain metastases or history of brain metastases.
- History of stroke within 6 months of treatment or other significant neurological limitations.
- Patients who have received more than 2 prior investigational treatments.
- Uncontrolled intercurrent illness
- Patients with a history of a myocardial infarction within the prior 6 months or, hospitalizations for decompensated congestive heart failure within the prior 6 months, or history of significant / symptomatic cardiac arrhythmias
Where it is running
- University of Wisconsin Hospital and Clinics — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.